AstraZeneca to acquire EsoBiotec for up to USD 1 billion Ruchika Sharma17 March 2025 3:30 PM ISTCambridge: AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies...
AstraZeneca Imfinzi approved in EU for limited stage small cell lung cancer Ruchika Sharma17 March 2025 10:30 AM ISTThe safety profile for Imfinzi was generally manageable and consistent with the known profile of this medicine.
AstraZeneca Imfinzi based perioperative regimen recommended for approval in EU for resectable non-small cell lung cancer Ruchika Sharma4 March 2025 10:15 AM ISTAstraZeneca has announced that Imfinzi (durvalumab) in combination with chemotherapy has been recommended for approval in the European Union (EU) for...
AstraZeneca-Daiichi Sankyo Enhertu recommended for approval in EU for patients with HER2-low or HER2-ultralow metastatic breast cancer Ruchika Sharma3 March 2025 12:15 PM ISTCambridge: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been recommended for approval in the European Union...
AstraZeneca Gets CDSCO Panel Nod To study Baxdrostat Tablets and Dapagliflozin Tablets Dr. Divya Colin7 Feb 2025 6:00 PM ISTNew Delhi: AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation...
Roche bags USFDA nod for companion diagnostic to identify patients with HER2-ultralow metastatic breast cancer eligible for Enhertu Ruchika Sharma1 Feb 2025 12:30 PM ISTBasel: Roche has announced that the U.S. Food and Drug Administration (FDA) has approved a label expansion for the PATHWAY anti-HER2/neu (4B5)...
AstraZeneca-Daiichi Sankyo Enhertu gets USFDA approval for HER2-ultralow metastatic breast cancer Ruchika Sharma28 Jan 2025 2:30 PM ISTAstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in the US for the treatment of adult patients with...
AstraZeneca-Daiichi Sankyo Datroway gets USFDA nod for previously treated Metastatic HR Positive, HER2 Negative Breast Cancer Ruchika Sharma20 Jan 2025 3:01 PM ISTTokyo: Daichi Sankyo has announced that DATROWAY (datopotamab deruxtecan-dlnk) has been approved in the U.S. for the treatment of adult...
USFDA approves AstraZeneca Calquence, bendamustine, rituximab combo for previously untreated mantle cell lymphoma Ruchika Sharma18 Jan 2025 1:30 PM ISTCambridge: AstraZeneca has announced that the Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) in combination with...
AstraZeneca-Daiichi Sankyo Datopotamab deruxtecan gets USFDA priority review in pretreated EGFR-mutated non-small cell lung cancer Ruchika Sharma14 Jan 2025 2:30 PM ISTDatopotamab deruxtecan is a specifically engineered TROP2-directed DXd antibody drug conjugate discovered by Daiichi Sankyo.
CDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal To Study antihypertensive drug Baxdrostat Dr. Divya Colin29 Dec 2024 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the pharmaceutical...
AstraZeneca Gets CDSCO Panel Nod To study Anti-Cancer Drug Rilvegostomig Dr. Divya Colin27 Dec 2024 6:00 PM ISTNew Delhi: Pharmaceutical major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Standard Control...
